Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
Clinical trial NCT01270828 · COMPLETED
Trial details
- NCT number
- NCT01270828
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-09-01
- Enrollment
- 806
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.